ARTICLE | Company News
Biota, Daiichi Sankyo sales and marketing update
October 11, 2010 7:00 AM UTC
Daiichi Sankyo will launch Inavir laninamivir 20 mg dry powder inhaler in Japan on Oct. 19 to treat influenza. The second-generation long-acting neuraminidase inhibitor (LANI) was approved in Japan ...